JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
44 hedge funds and large institutions have $27.9M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% more funds holding
Funds holding: 42 → 44 (+2)
Holders
44
Holding in Top 10
–
Calls
$680K
Puts
$444K
Top Buyers
| 1 | +$1.15M | |
| 2 | +$339K | |
| 3 | +$281K | |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$258K |
| 5 |
PP
PDT Partners
New York
|
+$116K |
Top Sellers
| 1 | -$415K | |
| 2 | -$300K | |
| 3 | -$127K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$92.8K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$85K |